How many shares of RARE does AQR CAPITAL MANAGEMENT LLC own?

As of 2026-Q1, AQR CAPITAL MANAGEMENT LLC holds 4.6M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN).

What is AQR CAPITAL MANAGEMENT LLC's RARE position worth?

As of 2026-Q1, AQR CAPITAL MANAGEMENT LLC's RARE position is worth $95.9M.

Is AQR CAPITAL MANAGEMENT LLC buying or selling RARE?

In 2026-Q1, AQR CAPITAL MANAGEMENT LLC increased their RARE position (+236.5% change in shares).

When did AQR CAPITAL MANAGEMENT LLC first buy RARE?

Based on available 13F filings, AQR CAPITAL MANAGEMENT LLC first reported a position in RARE in 2018-Q4. They have held the position across 26 quarters.

Back to

AQR CAPITAL MANAGEMENT LLC

RARE
26 quarters

Position history for AQR CAPITAL MANAGEMENT LLC's holdings in ULTRAGENYX PHARMACEUTICAL IN

Current Value

$95.9M

Current Shares

4.6M

Total Value Change

+$95.6M

Total Shares Change

+4.6M

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Increased	4.6M	+236.5%	$95.9M	0.0%	$22.07	48
2025-Q4	Increased	1.4M	+82.3%	$31.3M	0.0%	$22.78	44
2025-Q3	Increased	746,182	+195.7%	$22.4M	0.0%	$30.36	46
2025-Q2	Increased	252,333	+174.1%	$9.2M	0.0%	$36.52	45
2025-Q1	Decreased	92,047	-67.2%	$3.3M	0.0%	$37.82	0
2024-Q4	Decreased	280,547	-73.1%	$11.8M	0.0%	$42.27	0
2024-Q3	Increased	1M	+975.6%	$57.8M	0.1%	$54.43	47
2024-Q2	Decreased	97,100	-61.4%	$4M	0.0%	$41.10	0
2024-Q1	Increased	251,197	+47.2%	$11.7M	0.0%	$46.69	38
2023-Q4	New	170,689	-	$8.2M	0.0%	$47.82	38
2023-Q2	Exited	0	-100.0%	$0	0.0%	$46.65	0
2023-Q1	Increased	35,911	+125.7%	$1.4M	0.0%	$38.64	41
2022-Q4	Increased	15,914	+55.7%	$728,702	0.0%	$46.33	35
2022-Q3	New	10,222	-	$423,000	0.0%	$40.55	33
2021-Q3	Exited	0	-100.0%	$0	0.0%	$86.12	0
2021-Q2	Decreased	9,500	-67.0%	$906,000	0.0%	$96.29	0
2021-Q1	Decreased	28,784	-24.3%	$3.3M	0.0%	$112.06	0
2020-Q4	Increased	38,018	+30.8%	$5.3M	0.0%	$144.37	34
2020-Q3	Increased	29,059	+5.7%	$2.4M	0.0%	$85.10	28
2020-Q2	Increased	27,483	+16.2%	$2.2M	0.0%	$73.66	30
2020-Q1	Increased	23,647	+335.7%	$1.1M	0.0%	$44.32	40
2019-Q4	New	5,427	-	$232,000	0.0%	$42.69	32
2019-Q3	Exited	0	-100.0%	$0	0.0%	$42.50	0
2019-Q2	New	7,283	-	$462,000	0.0%	$63.50	33
2019-Q1	Exited	0	-100.0%	$0	0.0%	$69.36	0
2018-Q4	New	7,858	-	$342,000	0.0%	$41.87	33

Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.

RARE26 quarters

RARE
26 quarters